Related Experiment Video
Updated: Jun 6, 2026

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
Published on: April 21, 2017
Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis in Denmark 1994-2006: a nationwide
R Tuckuviene1, A L Christensen, J Helgestad
1Department of Clinical Biochemistry, Centre of Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark. rt@rn.dk
Insights
The incidence of pediatric arterial ischemic stroke (AIS) is rising annually, particularly in infants. Cerebral sinovenous thrombosis (CSVT) also peaks in infancy and adolescence, but its incidence remains stable.
Area of Science:
- Neurology
- Pediatrics
- Epidemiology
Background:
- Pediatric arterial ischemic stroke (AIS) and cerebral sinovenous thrombosis (CSVT) are rare but serious neurological conditions in children.
- Understanding their incidence, risk factors, and outcomes is crucial for improving diagnosis and management.
Purpose of the Study:
- To determine the incidence rates (IR) of pediatric AIS and CSVT.
- To characterize clinical features, risk factors, treatments, and outcomes for these conditions.
Main Methods:
- A population-based study using nationwide medical registries in Denmark.
- Inclusion of all patients aged 0-18 years hospitalized with first-ever AIS and/or CSVT between 1994 and 2006.
- Review of retrieved medical records for detailed data extraction.
Main Results:
- Identified 211 AIS and 40 CSVT cases, with IRs of 1.33 and 0.25 per 100,000 person-years, respectively.
- Incidence peaked in infancy for both AIS and CSVT, with an additional adolescent peak for CSVT.
- AIS incidence increased 3.9% annually; CSVT incidence remained stable. 48.2% received antithrombotic treatment with no major complications. 30-day fatality was 3.6%, and 56.2% experienced neurological sequelae.
Conclusions:
- Pediatric AIS incidence is increasing, especially in infants.
- CSVT incidence shows peaks in infancy and adolescence but has not changed significantly over time.
- Neurological sequelae are common following these events, highlighting the need for effective interventions.
Aim:
To assess the incidence rates (IR), clinical characteristics, risk factors, treatment and outcomes of paediatric arterial ischaemic stroke (AIS) and cerebral sinovenous thrombosis (CSVT).
Methods:
Using population-based, nationwide medical registries, we identified all patients aged 0-18 years at the time of hospitalization with first-ever AIS and/or CSVT in Denmark between 1994 and 2006. Medical records were retrieved and reviewed.
Results:
We identified 211 patients with AIS and 40 patients with CSVT corresponding to IRs of 1.33 (95% CI 1.16-1.52) and 0.25 (95% CI 0.19-0.34) per 100,000 person-years, respectively. The IRs peaked in infancy (<1 year) for both AIS and CSVT with an additional peak among adolescents (15-18 years) for CSVT. The IR of AIS increased 3.9% per year (p=0.036), whereas no changes were found for CSVT. In total, 48.2% of the patients received antithrombotic treatment; no major complications were observed. All-cause and thrombosis-related 30-day case fatality ratios were 3.6% and 2.4%, respectively; neurological sequelae were found in 56.2% of patients.
Conclusion:
The IR of AIS was highest in infants and had increased with 3.9% annually during the observation period. The IR of CSVT had an additional peak in adolescence and remained unchanged over time.
Related Concept Videos
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Stroke: Introduction and Types
Hemorrhagic Stroke ll: Pathophysiology
